BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 35352580)

  • 21. Sequence analysis of the emerging SARS-CoV-2 variant Omicron in South Africa.
    Wang L; Cheng G
    J Med Virol; 2022 Apr; 94(4):1728-1733. PubMed ID: 34897752
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Emergence of unique SARS-CoV-2 ORF10 variants and their impact on protein structure and function.
    Hassan SS; Lundstrom K; Serrano-Aroca Á; Adadi P; Aljabali AAA; Redwan EM; Lal A; Kandimalla R; El-Aziz TMA; Pal Choudhury P; Azad GK; Sherchan SP; Chauhan G; Tambuwala M; Takayama K; Barh D; Palu G; Basu P; Uversky VN
    Int J Biol Macromol; 2022 Jan; 194():128-143. PubMed ID: 34863825
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Haplotype distribution of SARS-CoV-2 variants in low and high vaccination rate countries during ongoing global COVID-19 pandemic in early 2021.
    Bui NN; Lin YT; Huang SH; Lin CW
    Infect Genet Evol; 2022 Jan; 97():105164. PubMed ID: 34848355
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SARS-CoV-2 Mutations and COVID-19 Clinical Outcome: Mutation Global Frequency Dynamics and Structural Modulation Hold the Key.
    Maurya R; Mishra P; Swaminathan A; Ravi V; Saifi S; Kanakan A; Mehta P; Devi P; Praveen S; Budhiraja S; Tarai B; Sharma S; Khyalappa RJ; Joshi MG; Pandey R
    Front Cell Infect Microbiol; 2022; 12():868414. PubMed ID: 35386683
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Summary of the Available Molecular Methods for Detection of SARS-CoV-2 during the Ongoing Pandemic.
    Arena F; Pollini S; Rossolini GM; Margaglione M
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33525651
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Omicron SARS-CoV-2 new variant: global prevalence and biological and clinical characteristics.
    Meo SA; Meo AS; Al-Jassir FF; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Dec; 25(24):8012-8018. PubMed ID: 34982465
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sequencing Using a Two-Step Strategy Reveals High Genetic Diversity in the S Gene of SARS-CoV-2 after a High-Transmission Period in Tunis, Tunisia.
    Fares W; Ghedira K; Gdoura M; Chouikha A; Haddad-Boubaker S; Khedhiri M; Ayouni K; Lamari A; Touzi H; Hammemi W; Medeb Z; Sadraoui A; Hogga N; Ben Alaya N; Triki H
    Microbiol Spectr; 2021 Dec; 9(3):e0063921. PubMed ID: 34756072
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Properties of Coronavirus and SARS-CoV-2.
    Malik YA
    Malays J Pathol; 2020 Apr; 42(1):3-11. PubMed ID: 32342926
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SARS-COV-2 Variants: Differences and Potential of Immune Evasion.
    Hirabara SM; Serdan TDA; Gorjao R; Masi LN; Pithon-Curi TC; Covas DT; Curi R; Durigon EL
    Front Cell Infect Microbiol; 2021; 11():781429. PubMed ID: 35118007
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SARS-CoV-2 Omicron Mutation Is Faster than the Chase: Multiple Mutations on Spike/ACE2 Interaction Residues.
    Kim S; Nguyen TT; Taitt AS; Jhun H; Park HY; Kim SH; Kim YG; Song EY; Lee Y; Yum H; Shin KC; Choi YK; Song CS; Yeom SC; Kim B; Netea M; Kim S
    Immune Netw; 2021 Dec; 21(6):e38. PubMed ID: 35036025
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CRISPR-Cas12a-Based Detection for the Major SARS-CoV-2 Variants of Concern.
    Liang Y; Lin H; Zou L; Zhao J; Li B; Wang H; Lu J; Sun J; Yang X; Deng X; Tang S
    Microbiol Spectr; 2021 Dec; 9(3):e0101721. PubMed ID: 34787487
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Minireview of progress in the structural study of SARS-CoV-2 proteins.
    Zhu G; Zhu C; Zhu Y; Sun F
    Curr Res Microb Sci; 2020 Sep; 1():53-61. PubMed ID: 33236001
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An Epidemiological Analysis of SARS-CoV-2 Genomic Sequences from Different Regions of India.
    Yadav PD; Nyayanit DA; Majumdar T; Patil S; Kaur H; Gupta N; Shete AM; Pandit P; Kumar A; Aggarwal N; Narayan J; Vijay N; Kalawat U; Sugunan AP; Munivenkatappa A; Sharma T; Devi S; Majumdar T; Jaryal S; Bakshi R; Joshi Y; Sahay R; Shastri J; Singh M; Kumar M; Rawat V; Dutta S; Yadav S; Krishnasamy K; Raut S; Biswas D; Borkakoty B; Verma S; Rani S; Deval H; Patel D; Turuk J; Malhotra B; Fomda B; Nag V; Jain A; Bhargava A; Potdar V; Cherian S; Abraham P; Gopal A; Panda S; Bhargava B
    Viruses; 2021 May; 13(5):. PubMed ID: 34067745
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evolutionary dynamics of SARS-CoV-2 nucleocapsid protein and its consequences.
    Rahman MS; Islam MR; Alam ASMRU; Islam I; Hoque MN; Akter S; Rahaman MM; Sultana M; Hossain MA
    J Med Virol; 2021 Apr; 93(4):2177-2195. PubMed ID: 33095454
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of Common Deletions in the Spike Protein of Severe Acute Respiratory Syndrome Coronavirus 2.
    Liu Z; Zheng H; Lin H; Li M; Yuan R; Peng J; Xiong Q; Sun J; Li B; Wu J; Yi L; Peng X; Zhang H; Zhang W; Hulswit RJG; Loman N; Rambaut A; Ke C; Bowden TA; Pybus OG; Lu J
    J Virol; 2020 Aug; 94(17):. PubMed ID: 32571797
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Replication of Severe Acute Respiratory Syndrome Coronavirus 2 in Human Respiratory Epithelium.
    Milewska A; Kula-Pacurar A; Wadas J; Suder A; Szczepanski A; Dabrowska A; Owczarek K; Marcello A; Ochman M; Stacel T; Rajfur Z; Sanak M; Labaj P; Branicki W; Pyrc K
    J Virol; 2020 Jul; 94(15):. PubMed ID: 32434888
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of SARS-CoV-2 mutations on protein structures and intraviral protein-protein interactions.
    Wu S; Tian C; Liu P; Guo D; Zheng W; Huang X; Zhang Y; Liu L
    J Med Virol; 2021 Apr; 93(4):2132-2140. PubMed ID: 33090512
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contributions of the N-terminal intrinsically disordered region of the severe acute respiratory syndrome coronavirus 2 nucleocapsid protein to RNA-induced phase separation.
    Zachrdla M; Savastano A; Ibáñez de Opakua A; Cima-Omori MS; Zweckstetter M
    Protein Sci; 2022 Sep; 31(9):e4409. PubMed ID: 36040256
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting ACLY efficiently inhibits SARS-CoV-2 replication.
    Yuen TT; Chan JF; Yan B; Shum CC; Liu Y; Shuai H; Hou Y; Huang X; Hu B; Chai Y; Yoon C; Zhu T; Liu H; Shi J; Zhang J; Cai JP; Zhang AJ; Zhou J; Yin F; Yuan S; Zhang BZ; Chu H
    Int J Biol Sci; 2022; 18(12):4714-4730. PubMed ID: 35874959
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel SARS-CoV-2 Variant in Travelers from Brazil to Japan.
    Fujino T; Nomoto H; Kutsuna S; Ujiie M; Suzuki T; Sato R; Fujimoto T; Kuroda M; Wakita T; Ohmagari N
    Emerg Infect Dis; 2021 Apr; 27(4):1243-5. PubMed ID: 33567247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.